HQL: Still Offers Attractive Value As Long As Interest Rates Decline

2025-11-06 04:20:36 ET

Overview

abrdn Life Sciences Investors ( HQL ) offers investors a diverse exposure to healthcare and life science businesses across the US. The fund has a goal of long-term capital appreciation, while simultaneously putting an emphasis on income generation. When I previously covered HQL, I issued a buy rating due to the attractive valuation at the time. Since then, HQL's share price has rapidly increased, so I wanted to revisit the fund to reassess its performance, valuation, and outlook for the remainder of the year....

Read the full article on Seeking Alpha

For further details see: